+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Botulinum Toxins Market by Type (AbobotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA), Application (Aesthetic, Therapeutic) - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337538
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Botulinum Toxins Market size was estimated at USD 4.93 billion in 2023, USD 5.69 billion in 2024, and is expected to grow at a CAGR of 15.48% to reach USD 13.51 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Botulinum Toxins Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Botulinum Toxins Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Botulinum Toxins Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Ajinomoto Bio-Pharma Services, Daewoong Pharmaceuticals Co.Ltd., Eisai Co., Ltd, Galderma S.A., Gufic Biosciences Ltd., Hugel, Inc., Hugh Source International Ltd., Ipsen group, JUVAPLUS, List Biological Labs, Inc., Medytox Inc., Merz GmbH & Co. KGaA, Object Pharma, Inc., Pfizer Inc., Revance Therapeutics, Inc., Shanghai Haohai Biological Technology Co., Ltd., and US Worldmeds, LLC.

Market Segmentation & Coverage

This research report categorizes the Botulinum Toxins Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • AbobotulinumtoxinA
    • IncobotulinumtoxinA
    • OnabotulinumtoxinA
    • RimabotulinumtoxinB
  • Application
    • Aesthetic
    • Therapeutic
      • Blepharospasm
      • Equinus Foot Associated With Lower Limb Spasticity
      • Hemifacial Spasm
      • Overactive Bladder & Neurogenic Bladder
      • Primary Axillary Hyperhidrosis
      • Spasmodic Dysphonia
      • Spasmodic Torticollis
      • Strabismus
      • Upper & Lower Limb Spasticity
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Botulinum Toxins Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Botulinum Toxins Market?
  3. What are the technology trends and regulatory frameworks in the Botulinum Toxins Market?
  4. What is the market share of the leading vendors in the Botulinum Toxins Market?
  5. Which modes and strategic moves are suitable for entering the Botulinum Toxins Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Botulinum Toxins Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of non-invasive cosmetic procedures
5.1.1.2. Increasing individuals highly conscious of their appearance
5.1.1.3. Rising aging population demand for procedures to make their skin look young
5.1.2. Restraints
5.1.2.1. Relatively high cost of the procedure
5.1.3. Opportunities
5.1.3.1. Increasing number of product approvals and launch of novel products
5.1.3.2. Surging awareness of therapeutic and cosmetic application of botulinum toxin
5.1.4. Challenges
5.1.4.1. Probable side effects of the procedure
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Botulinum Toxins Market, by Type
6.1. Introduction
6.2. AbobotulinumtoxinA
6.3. IncobotulinumtoxinA
6.4. OnabotulinumtoxinA
6.5. RimabotulinumtoxinB
7. Botulinum Toxins Market, by Application
7.1. Introduction
7.2. Aesthetic
7.3. Therapeutic
7.4.1. Blepharospasm
7.4.2. Equinus Foot Associated With Lower Limb Spasticity
7.4.3. Hemifacial Spasm
7.4.4. Overactive Bladder & Neurogenic Bladder
7.4.5. Primary Axillary Hyperhidrosis
7.4.6. Spasmodic Dysphonia
7.4.7. Spasmodic Torticollis
7.4.8. Strabismus
7.4.9. Upper & Lower Limb Spasticity
8. Americas Botulinum Toxins Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Botulinum Toxins Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Botulinum Toxins Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Ajinomoto Bio-Pharma Services
12.1.3. Daewoong Pharmaceuticals Co.Ltd.
12.1.4. Eisai Co., Ltd
12.1.5. Galderma S.A.
12.1.6. Gufic Biosciences Ltd.
12.1.7. Hugel, Inc.
12.1.8. Hugh Source International Ltd.
12.1.9. Ipsen group
12.1.10. JUVAPLUS
12.1.11. List Biological Labs, Inc.
12.1.12. Medytox Inc.
12.1.13. Merz GmbH & Co. KGaA
12.1.14. Object Pharma, Inc.
12.1.15. Pfizer Inc.
12.1.16. Revance Therapeutics, Inc.
12.1.17. Shanghai Haohai Biological Technology Co., Ltd.
12.1.18. US Worldmeds, LLC
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. BOTULINUM TOXINS MARKET RESEARCH PROCESS
FIGURE 2. BOTULINUM TOXINS MARKET SIZE, 2023 VS 2030
FIGURE 3. BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BOTULINUM TOXINS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BOTULINUM TOXINS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BOTULINUM TOXINS MARKET DYNAMICS
FIGURE 7. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BOTULINUM TOXINS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. BOTULINUM TOXINS MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BOTULINUM TOXINS MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BOTULINUM TOXINS MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BOTULINUM TOXINS MARKET SIZE, BY RIMABOTULINUMTOXINB, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 14. BOTULINUM TOXINS MARKET SIZE, BY BLEPHAROSPASM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BOTULINUM TOXINS MARKET SIZE, BY EQUINUS FOOT ASSOCIATED WITH LOWER LIMB SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BOTULINUM TOXINS MARKET SIZE, BY HEMIFACIAL SPASM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BOTULINUM TOXINS MARKET SIZE, BY OVERACTIVE BLADDER & NEUROGENIC BLADDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BOTULINUM TOXINS MARKET SIZE, BY PRIMARY AXILLARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BOTULINUM TOXINS MARKET SIZE, BY SPASMODIC DYSPHONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BOTULINUM TOXINS MARKET SIZE, BY SPASMODIC TORTICOLLIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. BOTULINUM TOXINS MARKET SIZE, BY STRABISMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. BOTULINUM TOXINS MARKET SIZE, BY UPPER & LOWER LIMB SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 33. CANADA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 36. MEXICO BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 50. CHINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. CHINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CHINA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 53. INDIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. INDIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 59. JAPAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. JAPAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. JAPAN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 77. THAILAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. THAILAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. THAILAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. DENMARK BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. DENMARK BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. DENMARK BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 90. EGYPT BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. EGYPT BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. EGYPT BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 93. FINLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. FINLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. FINLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 96. FRANCE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. FRANCE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. FRANCE BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 99. GERMANY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. GERMANY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. GERMANY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 105. ITALY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. ITALY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. ITALY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 114. NORWAY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. NORWAY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. NORWAY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 117. POLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. POLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. POLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 120. QATAR BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. QATAR BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 132. SPAIN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SPAIN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SPAIN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 141. TURKEY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. TURKEY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. TURKEY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 150. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 151. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 152. BOTULINUM TOXINS MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Ajinomoto Bio-Pharma Services
  • Daewoong Pharmaceuticals Co.Ltd.
  • Eisai Co., Ltd
  • Galderma S.A.
  • Gufic Biosciences Ltd.
  • Hugel, Inc.
  • Hugh Source International Ltd.
  • Ipsen group
  • JUVAPLUS
  • List Biological Labs, Inc.
  • Medytox Inc.
  • Merz GmbH & Co. KGaA
  • Object Pharma, Inc.
  • Pfizer Inc.
  • Revance Therapeutics, Inc.
  • Shanghai Haohai Biological Technology Co., Ltd.
  • US Worldmeds, LLC

Methodology

Loading
LOADING...

Table Information